Wird geladen...
Linagliptin Attenuates Diabetes-Induced Cerebral Pathological Neovascularization in a Blood Glucose-Independent Manner: Potential Role of ET-1
AIMS: We have shown that glycemic control with metformin or endothelin-1 (ET-1) inhibition with bosentan prevents and restores diabetes-mediated cerebral pathological remodeling and neovascularization. Our recent data suggest that linagliptin, a member of the dipeptidyl peptidase-4 inhibitor class o...
Gespeichert in:
| Veröffentlicht in: | Life Sci |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4882278/ https://ncbi.nlm.nih.gov/pubmed/26631506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lfs.2015.11.026 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|